T. Rowe Price Associates’s Eledon Pharmaceuticals ELDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$155K Buy
2025
Q4
$45K Hold
2025
Q3
$77K Hold
2025
Q2
$80K Buy